ESRX

Facebook Makes the Grade and Is Now a Buy

Yes, you read that correctly. After spending months in sell territory, Facebook has made a complete turnaround in a matter of days and is now a buy More 

50 Reasons to Take the American Consumer Seriously

Power to the people. Specifically, the American consumer. There's a reason why the June retail sales report dominated the headlines: its a critical U.S. sector More 

Pharmacy Wars: Walgreens vs. CVS

The two largest U.S. pharmacy chains have both come roaring back, but which one -- CVS or Walgreens -- is the better bet for investors? Let's break it down. More 

48 Ways to Prepare for Earnings Season

Second-quarter earnings season is just around the corner and it's probably not going to turn any heads. Here's a preview of what to expect More 

What To Make Of Tuesday’s Surprising Market Move

Wall Street clearly made up for the shortened trading week with a broad rally on Tuesday. Here's our new research on 50 stocks in Portfolio Grader More 

It Doesn’t Pay to Pile Into Hedge-Fund Favorites

Hedge funds' holdings flood the news each quarter, but reports such as the Goldman Sachs VIP List aren't necessarily a good source of actionable trade ideas. More 

Investor Alert: Know Before You Buy These 48 Blue Chips

Greetings from the Las Vegas Money Show! before I head off to my next seminar let me update you on our status for 48 blue chip stocks More